Sepsis Diagnostics Market Size, Trends

Global Sepsis Diagnostics Market: Growth Drivers and Challenges

Growth Drivers

Growing Prevalence of Hospital-Acquired Infections – Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. Urinary tract infections, pneumonia, and sepsis are the most frequent Hospital Acquired Infections. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses. For instance, in the United States, there is an increase in sepsis by 8.7% annually among patients admitted to a hospital. It is estimated that more than 1,000,000 cases of sepsis among hospitalized patients occur each year in the United States.
Development of Rapid Diagnostic Techniques for Sepsis Diagnosis – Sepsis is a very difficult condition to diagnose and the risk of mortality increases by 7.6%. Therefore, there is an increasing need to develop diagnostic tools for sepsis. Hence, the BACTEC Plus and BACTEC FX blood culturing instruments manufactured by BD Company (US) an automated microbial detection system offering a rapid diagnosis of sepsis in a turnaround time of three hours. Increase in Funding for Sepsis-Related Research Activities – According to the most recent reports, sepsis funding and directives have been included in the USD 1.7 trillion Omnibus spending bill passed and signed by President Joe Biden in January 2023. It is predicted that this boom would continue over the forecast period.
Increasing Burden of Sepsis – the global sepsis mortality rate is reported as 11 million in the year 2019. Reports from WHO cite that 85% of sepsis cases occur in low and middle-income countries. This increasing burden of sepsis is hence expected to contribute to the growth of the market in the forecast period.

Challenges

High cost of diagnostic devices - The increasing concern amongst people about the high cost of diagnostic devices is one of the major factors predicted to slow down the market growth. The cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high compared to the cost of blood culture tests priced as low as ~USD 28–35.
Shortage of skilled healthcare professionals
Lack of appropriate testing for sepsis

Global Sepsis Diagnostics Market Segmentation

The global market is segmented and analyzed for demand and supply by product into IBS with assay kits & reagents and blood culture media. Out of the two types of sepsis diagnostics, the blood culture media segment is estimated to gain the largest market share of about ~42% in the year 2035. The growth of the segment can be attributed to the increasing convenience and cost-effectiveness of this mode of testing. Further, the growing use of blood culture media by hospitals and pathology laboratories is also expected to contribute to the growth of the segment. For instance, it was found that the Sepifast system, which uses PCR techniques, had a better diagnostic performance when compared to blood cultures during an experimental study on patients from Thailand suffering from sepsis. As a result of increasing awareness about health care and the growing number of surgical procedures, it is also noted that instrument segments will continue to grow over the forecast period. For example, in September 2019 Guthrie, a U.S.-based Integrated Health System, started to use Wolters Kluwer Point of Care advisors for detecting and treating Sepsis at four hospitals within the area. All these factors are anticipated to contribute to the growth of the segment.

The global sepsis diagnostics market is also segmented and analyzed for demand and supply by technology into microbiology, immunoassays, and flow cytometry. Amongst these three segments, the microbiology segment is expected to garner a significant share of around ~45% in the year 2035. It is based on the fact that microbiological technology makes use of culture media tests to detect and identify sepsis organisms in a precise manner. Moreover, the growing segment is being driven by New Strategic Initiatives undertaken by major players. For instance, in April 2019, BD introduced the new BACTEC plasma quality monitoring media to help identify and reduce sepsis incidence among patients who receive blood transfusions. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global sepsis diagnostics market includes the following segments:

By Product	Assay Kits & Reagents Blood Culture Media
By Technology	Microbiology Immunoassays Flow Cytometry
By Pathogen	Bacterial Sepsis Fungal Sepsis Others
By Testing Type	Laboratory Testing POC Testing

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Global Sepsis Diagnostics Market Regional Synopsis

The market share of sepsis diagnostics in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~39% by the end of 2035. The growth of the market can be attributed majorly to the increasing and developed healthcare infrastructure in the region. This has led to an increase in the number of advanced diagnostic equipment and programs being used across the region. Furthermore, the market's growth is supported by a high presence of key players and an adequate reimbursement framework across that region. Moreover, demand for new diagnostics solutions is expected to rise due to a high incidence of sepsis and infectious diseases. For instance, according to the Centers for Disease Control and Prevention, in August 2021, approximately 1.7 million adults in America develop sepsis, and nearly 270,000 Americans die due to sepsis. It was also found that 1 in 3 patients who die in a hospital have sepsis. Hence, its diagnosis will increase and the market will grow as a result of the high number of cases in the country. The market will also be supported by increasing investments in research and development to diagnose sepsis. For example, Cytovale Inc., in April 2020, expanded its partnership with the Biomedical Advanced Research and Development Authority, BARDA, to diagnose sepsis in patients with potential respiratory infections, including COVID-19. Research costs are estimated to be US$1.2 billion. 5.9 million.

The Asia Pacific sepsis diagnostics market is estimated to be the second largest, registering a significant share by the end of 2035. The growth of the market can be attributed majorly to the increasing research efforts by key players in the last few years that have fueled a growing need to rapidly diagnose sepsis. For instance, Cytovale Inc. announced a partnership with the Biomedical Advanced Research and Development Authority, BARDA, for the diagnosis of sepsis in patients with infectious respiratory disease, including COVID-19, in April 2020. In addition to a contribution of 3.83 million by BARDA, the research was expected to amount to US$ 5.9 million. In addition, the region's launch of effective treatments and clinical trials are also anticipated to boost the market growth during the forecast period.

Further, the sepsis diagnostics market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the increasing number of fatalities caused by sepsis in the region. There is a series of trials in order to reduce the number of diseases that have been caused, as well as by applying novel diagnostics and therapeutic approaches. The growing incidence of sepsis, coupled with a rising number of diagnostic laboratories across the country, is driving the market. For instance, the Pasteur Institute, a non-profit foundation dedicated to studying vaccines and diseases reports that the sepsis-related death rate in France is nearly 27%. All these factors contribute to the growth of the market.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the sepsis diagnostics market?

Ans: Increasing prevalence of hospital-acquired infections, the rising burden of sepsis in the world, and rising diagnostic developments are the major factors driving the market growth.

2) What would be the CAGR of sepsis diagnostics market over the forecast period?

Ans: The market size of sepsis diagnostics is anticipated to attain a CAGR of ~11.90% over the forecast period, i.e., 2023 â€“ 2035.

3) What are the challenges affecting the sepsis diagnostics market growth?

Ans: High cost of diagnostics devices, and the shortage of skilled healthcare professionals are estimated to be the growth hindering factors for the market expansion.

4) Which region will provide more business opportunities for growth of sepsis diagnostics market in future?

Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

5) Who are the major players dominating the sepsis diagnostics market?

Ans: The major players in the market are bioMÃ©rieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter, Inc.), Cepheid, Beckman Coulter, Inc., Luminex Corp., Bruker Corp., Amara Health Analytics

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the sepsis diagnostics market?

Ans: The market is segmented by product, technology, pathogen, testing type, and by region.

8) Which segment captures the largest market size in the product segment in the sepsis diagnostics market?

Ans: The blood culture media segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Base Year	2022
Forecast Year	2023-2035
CAGR	~11.90%
Base Year Market Size (2022)	~ USD 2 Billion
Forecast Year Market Size (2035)	~ USD 6 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Global Sepsis Diagnostics Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Global Sepsis Diagnostics Market: Key Insights